These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 1578361

  • 21. Cryoprecipitate of intermediate purity produced in a closed thaw-siphon system from DDAVP stimulated blood donor plasma.
    Konecka G, Bykowska K, Ludwicka A, Letowska M, Wegrzynowicz Z, Sablinski J, Lopaciuk S.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):565-70. PubMed ID: 1714861
    [Abstract] [Full Text] [Related]

  • 22. Desmopressin (DDAVP) for treatment of disorders of hemostasis.
    Mannucci PM.
    Prog Hemost Thromb; 1986; 8():19-45. PubMed ID: 3104987
    [Abstract] [Full Text] [Related]

  • 23. Characterization of acute hemodynamic effects of antidiuretic agonists in conscious dogs.
    Liard JF.
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):174-80. PubMed ID: 2452311
    [Abstract] [Full Text] [Related]

  • 24. Regulated release of VWF and FVIII and the biologic implications.
    Haberichter SL, Shi Q, Montgomery RR.
    Pediatr Blood Cancer; 2006 May 01; 46(5):547-53. PubMed ID: 16470522
    [Abstract] [Full Text] [Related]

  • 25. PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2.
    van Vliet HH, Kappers-Klunne MC, Leebeek FW, Michiels JJ.
    Thromb Haemost; 2008 Sep 01; 100(3):462-8. PubMed ID: 18766263
    [Abstract] [Full Text] [Related]

  • 26. Response of patients with hemophilia A and von Willebrand disease to desmopressin (DDAVP).
    Santiago-Borrero PJ, Casanova R.
    Bol Asoc Med P R; 1990 May 01; 82(5):207-10. PubMed ID: 2115785
    [Abstract] [Full Text] [Related]

  • 27. Pre-treatment of porcine pulmonary xenograft with desmopressin: a novel strategy to attenuate platelet activation and systemic intravascular coagulation in an ex-vivo model of swine-to-human pulmonary xenotransplantation.
    Kim YT, Lee HJ, Lee SW, Kim JY, Wi HC, Park SJ, Bae SJ, Kang HJ.
    Xenotransplantation; 2008 Feb 01; 15(1):27-35. PubMed ID: 18333911
    [Abstract] [Full Text] [Related]

  • 28. Concentrated DDAVP: further improvement in the management of mild factor VIII deficiencies.
    Ghirardini A, Mariani G, Iacopino G, Tirindelli MC, Solinas S, Moretti T.
    Thromb Haemost; 1987 Oct 28; 58(3):896-8. PubMed ID: 3124287
    [Abstract] [Full Text] [Related]

  • 29. Shortening of bleeding time by 1-deamino-8-arginine vasopressin (DDAVP) in the absence of platelet von Willebrand factor in Gray platelet syndrome.
    Pfueller SL, Howard MA, White JG, Menon C, Berry EW.
    Thromb Haemost; 1987 Dec 18; 58(4):1060-3. PubMed ID: 3502198
    [Abstract] [Full Text] [Related]

  • 30. SK&F 105494: a potent antidiuretic hormone antagonist devoid of partial agonist activity in dogs.
    Caldwell N, Brickson B, Kinter LB, Brooks DP, Huffman WF, Stassen FL, Albrightson-Winslow C.
    J Pharmacol Exp Ther; 1988 Dec 18; 247(3):897-901. PubMed ID: 3204522
    [Abstract] [Full Text] [Related]

  • 31. Response of factor VIII/von Willebrand factor to intranasal DDAVP in healthy subjects and mild haemophiliacs (with observations in patients with combined deficiency of factors V and VIII).
    Garcia VV, Silva IA, Borrasca AL.
    Thromb Haemost; 1982 Aug 24; 48(1):91-3. PubMed ID: 6813999
    [Abstract] [Full Text] [Related]

  • 32. Discrepant increase in factor VIII: C and von Willebrand factor after DDAVP infusion in a patient with variant von Willebrand's disease.
    Casonato A, Sartori MT, Pontara E, Bertomoro A, Dannhäuser D, Girolami.
    Blood Coagul Fibrinolysis; 1991 Aug 24; 2(4):567-73. PubMed ID: 1768767
    [Abstract] [Full Text] [Related]

  • 33. Comparative study of intranasal, subcutaneous and intravenous administration of desamino-D-arginine vasopressin (DDAVP).
    Köhler M, Hellstern P, Miyashita C, von Blohn G, Wenzel E.
    Thromb Haemost; 1986 Feb 28; 55(1):108-11. PubMed ID: 3085261
    [Abstract] [Full Text] [Related]

  • 34. Intranasal DDAVP induced increases in plasma von Willebrand factor alter the pharmacokinetics of high-purity factor VIII concentrates in severe haemophilia A patients.
    Deitcher SR, Tuller J, Johnson JA.
    Haemophilia; 1999 Mar 28; 5(2):88-95. PubMed ID: 10215955
    [Abstract] [Full Text] [Related]

  • 35. Venostasis but not DDAVP infusion provokes the plasma fibronectin increase.
    Letowska M, Bykowska K, Sablinski J, Lopaciuk S, Kopeć M.
    Thromb Haemost; 1990 Oct 22; 64(2):294-6. PubMed ID: 2270537
    [Abstract] [Full Text] [Related]

  • 36. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
    Casonato A, Pontara E, Dannhäuser D, Bertomoro A, Sartori MT, Girolami A.
    Haematologia (Budap); 1994 Oct 22; 26(2):97-109. PubMed ID: 7890268
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders.
    Hanebutt FL, Rolf N, Loesel A, Kuhlisch E, Siegert G, Knoefler R.
    Haemophilia; 2008 May 22; 14(3):524-30. PubMed ID: 18284449
    [Abstract] [Full Text] [Related]

  • 38. The use of desmopressin acetate (DDAVP) as a test of the fibrinolytic capacity of patients--analysis of responders and non-responders.
    Brommer EJ, Barrett-Bergshoeff MM, Allen RA, Schicht I, Bertina RM, Schalekamp MA.
    Thromb Haemost; 1982 Oct 29; 48(2):156-61. PubMed ID: 6817444
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Repeated infusions of DDAVP induce low response of FVIII and vWF but not of plasminogen activators.
    Vicente V, Estellés A, Laso J, Moraleda JM, Rivera J, Aznar J.
    Thromb Res; 1993 Apr 15; 70(2):117-22. PubMed ID: 8322282
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.